Syneos Health Inc   (SYNH)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $42.9800 $0.01 0.023%
Day's High: $42.99 Week Perf: 0.49 %
Day's Low: $ 42.97 30 Day Perf: 1.03 %
Volume (M): 7,386 52 Wk High: $ 43.64
Volume (M$): $ 317,459 52 Wk Avg: $42.51
Open: $42.98 52 Wk Low: $41.75

 Market Capitalization (Millions $) 4,485
 Shares Outstanding (Millions) 104
 Employees 25,000
 Revenues (TTM) (Millions $) 5,419
 Net Income (TTM) (Millions $) 71
 Cash Flow (TTM) (Millions $) -24
 Capital Exp. (TTM) (Millions $) 91

Syneos Health Inc
Syneos Health Inc. is a leading global provider of integrated healthcare services, offering a broad range of solutions to the world's most innovative biopharmaceutical companies. The company is headquartered in Morrisville, North Carolina, and has a presence in over 110 countries worldwide, with more than 23,000 employees.

Syneos Health is a combination of two industry-leading organizations: INC Research and inVentiv Health. The merger created a new kind of company with a unified purpose, unparalleled experience, and expertise in clinical development, commercialization, and consulting services.

Syneos Health provides a broad range of services across the entire product development and commercialization lifecycle, including clinical research, data analytics, regulatory consulting, medical communications, creative services, commercialization services, and quality assurance. The company's mission is to improve the lives of patients by accelerating the development and delivery of innovative therapies.

Syneos Health has a deep understanding of the challenges and opportunities in the healthcare industry and leverages its global footprint, scientific expertise, and powerful data analytics capabilities to help its clients navigate the changing healthcare landscape. The company works with pharmaceutical, biotech, and medical device companies to bring new therapies and products to market faster and more efficiently.

Syneos Health is committed to innovation and invests heavily in research and development to stay at the forefront of the industry. The company has a strong culture of collaboration and teamwork, which helps it deliver exceptional value to clients.

In summary, Syneos Health is a leading global provider of integrated healthcare services that offers a full range of solutions to the world's most innovative biopharmaceutical companies, with a mission to improve the lives of patients by accelerating the development and delivery of innovative therapies.

   Company Address: 1030 Sync Street Morrisville 27560 NC
   Company Phone Number: 876-9300   Stock Exchange / Ticker: NASDAQ SYNH


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Syneos Health Inc

Syneos Health Inc faces significant income decline and revenue challenges in the second quarter of 2023 earnings season

Syneos Health Inc, a leading company in the Medical Laboratories industry, has experienced a 0.35% increase in its shares over the past seven days. However, this positive trend falls short of the company's 52-week average on the NASDAQ by -0.8%. While the year-to-date performance stands at a commendable 16.87%, the recent financial results present concerning figures that may impact the company's future prospects.
1. Declining Income and Revenue Growth:
In the second quarter of the 2023 earnings season, Syneos Health Inc witnessed a significant income decline of -98.67% compared to the same period in the previous year. Despite a revenue growth of 0.393%, the company recorded a net profit of only $0.793 million, compared to $77.744 million in the corresponding period a year ago. These figures indicate considerable challenges in maintaining profitability and highlight the need for strategic measures to reverse the income decline.

Syneos Health Inc

Syneos Health Inc Faces Challenges as Profits Slip, But Revenue Holds Steady in First Quarter 2023

Syneos Health Inc, a leading provider of clinical research and commercial solutions to biopharmaceutical companies worldwide, recently reported its financial results for the first quarter of 2023. However, the company was not able to maintain the profitability that it had achieved in the previous year, as it slipped into a loss of $-0.70 per share as compared to a gain of $0.44 per share in the corresponding period a year prior. Furthermore, income per share also fell from $0.54 per share from the previous reporting period.
Despite this decline, the company's revenue increased moderately by 1.538% to $1.36 billion from $1.34 billion in the corresponding reporting period a year back. However, sequentially revenue decreased by -0.226% from $1.36 billion. The company logged a net loss of $-72.149 million, instead of a bottom line of $46.176 million achieved in the corresponding reporting period a year before.


Syneos Health Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com